spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

doi: 10.1242/10.1242/jcs.00097


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCaig, C.
Right arrow Articles by Holly, J. M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCaig, C.
Right arrow Articles by Holly, J. M. P.
Journal of Cell Science 115, 4293-4303 (2002)
doi: 10.1242/jcs.00097


Research Article

Intrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectin

Catherine McCaig, Claire M. Perks* and Jeff M. P. Holly

Division of Surgery, Department of Hospital Medicine, Bristol Royal Infirmary, Bristol, BS2 8HW, UK

* Author for correspondence (e-mail: claire.m.perks{at}bristol.ac.uk)

Accepted 6 August 2002

The insulin-like growth factor binding proteins (IGFBPs) have IGF-independent differential effects on cell function. We investigated whether they can affect integrin-receptor-mediated cell attachment to different extracellular matrix (ECM) components in Hs578T cells.

Cell attachment to a general ECM gel was unaffected by IGFBP-1 and -6 but was significantly increased by IGFBP-4 and -5 and decreased by IGFBP-2 and -3. Similar results were obtained for attachment to laminin or collagen type IV. Attachment to fibronectin, however, was increased by IGFBP-3 and decreased by IGFBP-5. The actions of IGFBP-3 and -5 on cell attachment to ECM were lost in the presence of a soluble Arg-Gly-Asp (RGD)-containing fibronectin fragment. Thrombospondin reversed the actions of IGFBP-3 on cell attachment, but IGFBP-5 still increased cell attachment.

On plastic, neither IGFBP-3 nor -5 alone affected cell viability; although ceramide-induced apoptosis was enhanced by IGFBP-3 but reduced by IGFBP-5. The presence of RGD reversed the action of IGFBP-5 on cell death but attenuated that of IGFBP-3. With cells grown on fibronectin, the action of IGFBP-3 was reversed, and it conferred cell survival, whereas the survival effect of IGFBP-5 was lost.

In summary we have demonstrated that IGFBP-3 and -5 both have intrinsic effects on cell survival. In each case the presence of fibronectin or fibronectin fragments determines whether susceptibility to apoptosis is increased or decreased. These effects on cell survival are paralleled by acute effects on integrin receptor function; IGFBP-3 and -5 were able to either enhance or inhibit cell attachment in the presence of fibronectin. Cell survival is tightly controlled by cues from the ECM and from growth factors, particularly the IGFs. Our findings indicate that, in addition to being crucial modulators of IGF actions, the IGFBPs have direct actions on cell attachment and survival that are specific and dependent upon the matrix components present.

Key words: IGFBP, Cell adhesion, ECM, Breast epithelia, Apoptosis, Integrin, Fibronectin




This article has been cited by other articles:


Home page
EndocrinologyHome page
J. L. Martin and S. Jambazov
Insulin-Like Growth Factor Binding Protein-3 in Extracellular Matrix Stimulates Adhesion of Breast Epithelial Cells and Activation of p44/42 Mitogen-Activated Protein Kinase
Endocrinology, September 1, 2006; 147(9): 4400 - 4409.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Burrows, J. M. P. Holly, N. J. Laurence, E. G. Vernon, J. V. Carter, M. A. Clark, J. McIntosh, C. McCaig, Z. E. Winters, and C. M. Perks
Insulin-Like Growth Factor Binding Protein 3 Has Opposing Actions on Malignant and Nonmalignant Breast Epithelial Cells that Are Each Reversible and Dependent upon Cholesterol-Stabilized Integrin Receptor Complexes
Endocrinology, July 1, 2006; 147(7): 3484 - 3500.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
A. G Renehan, M. Harvie, and A. Howell
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on.
Endocr. Relat. Cancer, June 1, 2006; 13(2): 273 - 278.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Zhao, P. Yin, L. A. Bach, and C. Duan
Several Acidic Amino Acids in the N-domain of Insulin-like Growth Factor-binding Protein-5 Are Important for Its Transactivation Activity
J. Biol. Chem., May 19, 2006; 281(20): 14184 - 14191.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
P J Jenkins, S Khalaf, W Ogunkolade, K McCarthy, T David, R E Hands, D Davies, and S A Bustin
Differential expression of IGF-binding protein-3 in normal and malignant colon and its influence on apoptosis
Endocr. Relat. Cancer, December 1, 2005; 12(4): 891 - 901.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
J M Fleming, B J Leibowitz, D E Kerr, and W S Cohick
IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells
J. Endocrinol., July 1, 2005; 186(1): 165 - 178.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. J. Butt, K. A. Dickson, S. Jambazov, and R. C. Baxter
Enhancement of Tumor Necrosis Factor-{alpha}-Induced Growth Inhibition by Insulin-Like Growth Factor-Binding Protein-5 (IGFBP-5), But Not IGFBP-3 in Human Breast Cancer Cells
Endocrinology, July 1, 2005; 146(7): 3113 - 3122.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
B. M. Jacobsen, S. A. Schittone, J. K. Richer, and K. B. Horwitz
Progesterone-Independent Effects of Human Progesterone Receptors (PRs) in Estrogen Receptor-Positive Breast Cancer: PR Isoform-Specific Gene Regulation and Tumor Biology
Mol. Endocrinol., March 1, 2005; 19(3): 574 - 587.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
W. Hu, R. Xu, G. Zhang, J. Jin, Z. M. Szulc, J. Bielawski, Y. A. Hannun, L. M. Obeid, and C. Mao
Golgi Fragmentation Is Associated with Ceramide-induced Cellular Effects
Mol. Biol. Cell, March 1, 2005; 16(3): 1555 - 1567.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
L. J. Cobb, D. A. M. Salih, I. Gonzalez, G. Tripathi, E. J. Carter, F. Lovett, C. Holding, and J. M. Pell
Partitioning of IGFBP-5 actions in myogenesis: IGF-independent anti-apoptotic function
J. Cell Sci., May 1, 2004; 117(9): 1737 - 1746.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Q. Xu, S. Li, Y. Zhao, T. J. Maures, P. Yin, and C. Duan
Evidence That IGF Binding Protein-5 Functions as a Ligand-Independent Transcriptional Regulator in Vascular Smooth Muscle Cells
Circ. Res., March 19, 2004; 94(5): e46 - e54.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Xu, B. Yan, S. Li, and C. Duan
Fibronectin Binds Insulin-like Growth Factor-binding Protein 5 and Abolishes Its Ligand-dependent Action on Cell Migration
J. Biol. Chem., February 6, 2004; 279(6): 4269 - 4277.
[Abstract] [Full Text] [PDF]




© The Company of Biologists Ltd 2002